Clinical trial
Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the…
NCT00294788 · Probiomics Ltd, Industry · Unknown status
Key facts
| NCT number | NCT00294788 |
|---|---|
| Title | Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines |
| Official title | Phase I/II Placebo-Controlled Study of Consumption of a Probiotic on HAI Titre Following Influenza Vaccination of Healthy Adult Subjects |
| Lead sponsor | Probiomics Ltd, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological, Drug |
| Interventions | Fluvax, PCC® (Lactobacillus fermentum VRI 003) |
| Enrollment | 300 |
| Start date | Mar 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Feb 22, 2006 |
| Last update posted | Jan 9, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: